Company Filing History:
Years Active: 2020-2024
Title: Innovations of Stephan Menzel in Antigen-Binding Polypeptides
Introduction
Stephan Menzel is a notable inventor based in Hamburg, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of antigen-binding polypeptides. His work focuses on the diagnosis and treatment of diseases associated with increased CD38 expression.
Latest Patents
Menzel holds two patents related to his innovative work. His latest patents involve polypeptides that specifically bind to CD38. These inventions are suitable for diagnosing and therapeutically treating diseases characterized by elevated CD38 expression. The patents also disclose conjugates and pharmaceutical compositions that include these polypeptides. Furthermore, Menzel's inventions encompass methods for detecting CD38 and/or CD38-expressing cells in biological samples. He has also described processes for purifying and concentrating CD38 and/or CD38-expressing cells using these antigen-binding polypeptides.
Career Highlights
Stephan Menzel is affiliated with the University Medical Center Hamburg-Eppendorf, where he continues to advance his research and innovations. His work has garnered attention in the scientific community for its potential applications in medical diagnostics and therapeutics.
Collaborations
Throughout his career, Menzel has collaborated with esteemed colleagues, including Friedrich Nolte and Peter Bannas. These collaborations have contributed to the development and refinement of his innovative technologies.
Conclusion